OTCMKTS:SZLSF Stagezero Life Sciences (SZLSF) Stock Price, News & Analysis $0.02 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestBuy This Stock About Stagezero Life Sciences Stock (OTCMKTS:SZLSF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SZLSF alerts:Sign Up Key Stats Today's Range$0.02▼$0.0250-Day Range$0.00▼$0.0352-Week Range$0.00▼$1.00VolumeN/AAverage Volume3,773 shsMarket Capitalization$2.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada. Read More Receive SZLSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stagezero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address SZLSF Stock News HeadlinesStageZero Life Sciences Ltd. (SZLSF)July 27, 2024 | finance.yahoo.comStageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational UpdateMay 17, 2024 | finanznachrichten.deElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.July 6 at 2:00 AM | Brownstone Research (Ad)StageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade OrderApril 5, 2024 | finanznachrichten.deStagezero Life Sciences GAAP EPS of -$0.01, revenue of $0.75MNovember 15, 2023 | seekingalpha.comStageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special MeetingJune 7, 2023 | finance.yahoo.comDually-Listed Healthcare Stock Rallies On Q1 ResultsMay 17, 2023 | theglobeandmail.comStageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023May 15, 2023 | finance.yahoo.comSee More Headlines SZLSF Stock Analysis - Frequently Asked Questions How have SZLSF shares performed this year? Stagezero Life Sciences' stock was trading at $0.0016 at the beginning of the year. Since then, SZLSF shares have increased by 1,325.0% and is now trading at $0.0228. How do I buy shares of Stagezero Life Sciences? Shares of SZLSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryN/A Current SymbolOTCMKTS:SZLSF CIK1454263 Webwww.stagezerolifesciences.com Phone(855) 420-7140Fax905-209-2031Employees80Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3.80 million Price / Sales0.74 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares123,530,000Free Float120,395,000Market Cap$2.82 million OptionableNot Optionable Beta-0.15 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:SZLSF) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredFINAL HOURS: $9 Income ETF Access VANISHES at MIDNIGHTTHIS IS IT. Your FINAL CHANCE. At midnight, our 82% OFF July 4th deal disappears FOREVER. The countdown ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stagezero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stagezero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.